Open-Label Study of 18F-mFBG for Imaging Myocardial Sympathetic Innervation
NCT04535193
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
10
Enrollment
INDUSTRY
Sponsor class
Conditions
Cardiovascular Diseases
Interventions
DRUG:
18F-mFBG for intravenous administration
Sponsor
Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC)
Collaborators
[object Object]